Ann: Q4 FY23 Quarterly Activities Report and Appendix 4C, page-61

hey Pallab

it definitely isnt growing like the 2020-2022 days right now; the company has put a lot of emphasis of pipeline of UK NHS operations
there are known delays out of their control
they have stated trusts have been given budget to spend by march 2024- that is a very strong "pipeline" signal that they have pipeline, its not won yet, but they are expecting to win some of that pipeline before March 2024. Some solid wins on the way
alcidions tech has such a good name in what it delivers and the hospitals love alcidions people. The referencability will really help them imho to continue to upsell into their existing and land new deals.
your comment about cash is poorly researched imho. Yes they had 17 million last year but last quartet they announced they had 11, then it went up to 15. Now 14.4 million or whatever it is AFTER they have paid out the silverlink tranche payment; thats a very solid cash position. Wven if they are burning through 2 million a year thats 7 years runway. But they are cash flow positive
looking back to 2021 and 2022 they actually want to get enough tech capability to eventually compete against the likes of Cerner. Cerner started small when first founded. And look at what Oracle acquired them for. Alcidion could be another ASX Unicorn eventually. Id like to see their growth back to 40-50% yoy. At some point this year i am expecting an announcement into a new major region; europe or canada maybe.
but their cash and burn rate is fine imho. They have showed they can turned to cash flow positive thats a major hurdle